Transient Eruption of Verrucous Keratoses During Encorafenib Therapy: Adverse Event or Paraneoplastic Phenomenon?

Cutis. 2024 Sep;114(3):E17-E19. doi: 10.12788/cutis.1108.

Authors

Alex A Marti¹, Melissa A Willis¹, Vincent Liu¹

Affiliation

¹ Alex A. Marti is from the Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City. Drs. Willis and Liu are from the Department of Dermatology, The University of Iowa Hospitals and Clinics, Iowa City.

PMID: 39413319
DOI: 10.12788/cutis.1108

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects
Carbamates* / administration & dosage
Carbamates* / adverse effects
Drug Eruptions / diagnosis
Drug Eruptions / etiology
Female
Humans
Keratosis / chemically induced
Male
Middle Aged
Paraneoplastic Syndromes / diagnosis
Sulfonamides* / administration & dosage
Sulfonamides* / adverse effects

Substances

encorafenib
Sulfonamides
Carbamates
Antineoplastic Agents